{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:43:34Z","timestamp":1778499814310,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Samsung Medical Center","award":["#GFO217006"],"award-info":[{"award-number":["#GFO217006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0702-5","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T08:09:00Z","timestamp":1504080540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevalence and risk factors for type 2 diabetes mellitus with Prader\u2013Willi syndrome: a single center experience"],"prefix":"10.1186","volume":"12","author":[{"given":"Aram","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"702_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009531","volume":"7","author":"DC Bittel","year":"2005","unstructured":"Bittel DC, Butler MG. Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med. 2005;7:1\u201320.","journal-title":"Expert Rev Mol Med"},{"key":"702_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","volume":"17","author":"SB Cassidy","year":"2009","unstructured":"Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17:3\u201313.","journal-title":"Eur J Hum Genet"},{"key":"702_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","volume":"22","author":"P Burman","year":"2001","unstructured":"Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev. 2001;22:787\u201399.","journal-title":"Endocr Rev"},{"key":"702_CR4","volume":"10","author":"SM Lim","year":"2015","unstructured":"Lim SM, Choi DP, Rhee Y, Kim HC. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS high school study. PLoS One. 2015;10:e0125238.","journal-title":"PLoS One"},{"key":"702_CR5","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","volume":"86","author":"AP Goldstone","year":"2001","unstructured":"Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86:4330\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR6","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ajmg.a.34171","volume":"155a","author":"M Sinnema","year":"2011","unstructured":"Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, van Nieuwpoort IC, Drent ML, Curfs LM, et al. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A. 2011;155a:2112\u201324.","journal-title":"Am J Med Genet A"},{"key":"702_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/dc14-2391","volume":"38","author":"WC Hsu","year":"2015","unstructured":"Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38:150\u20138.","journal-title":"Diabetes Care"},{"key":"702_CR8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240.","journal-title":"BMJ"},{"key":"702_CR9","doi-asserted-by":"crossref","unstructured":"Koebnick C, Smith N, Coleman KJ, Getahun D, Reynolds K, Quinn VP, et al. Prevalence of Extreme Obesity in a Multiethnic Cohort of Children and Adolescents. The Journal of Pediatrics. 2010;157 26\u201331.e2","DOI":"10.1016\/j.jpeds.2010.01.025"},{"key":"702_CR10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"702_CR11","doi-asserted-by":"crossref","unstructured":"Classification and Diagnosis of Diabetes. Diabetes Care. 2016;39:S13\u201322.","DOI":"10.2337\/dc16-S005"},{"key":"702_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","volume":"45","author":"M Greiner","year":"2000","unstructured":"Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45:23\u201341.","journal-title":"Prev Vet Med"},{"key":"702_CR13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S001216220100202X","volume":"44","author":"JV Butler","year":"2002","unstructured":"Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002;44:248\u201355.","journal-title":"Dev Med Child Neurol"},{"key":"702_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1651-2227.1999.tb14418.x","volume":"88","author":"WB Zipf","year":"1999","unstructured":"Zipf WB. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy. Acta Paediatr Suppl. 1999;88:115\u20137.","journal-title":"Acta Paediatr Suppl"},{"key":"702_CR15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.numecd.2016.05.010","volume":"26","author":"D Fintini","year":"2016","unstructured":"Fintini D, Grugni G, Bocchini S, Brufani C, Di Candia S, Corrias A, et al. Disorders of glucose metabolism in Prader-Willi syndrome: results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis. 2016;26:842\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"702_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1297\/cpe.20.33","volume":"20","author":"T Tsuchiya","year":"2011","unstructured":"Tsuchiya T, Oto Y, Ayabe T, Obata K, Murakami N, Nagai T. Characterization of diabetes mellitus in Japanese prader-willi syndrome. Clin Pediatr Endocrinol. 2011;20:33\u20138.","journal-title":"Clin Pediatr Endocrinol"},{"key":"702_CR17","volume":"9","author":"BK Koo","year":"2014","unstructured":"Koo BK, Lee C-H, Yang BR, Hwang S-s, Choi N-K. The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea. A National Health Insurance Database Study PLOS ONE. 2014;9:e110650.","journal-title":"A National Health Insurance Database Study PLOS ONE"},{"key":"702_CR18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3803\/EnM.2016.31.4.510","volume":"31","author":"KH Ha","year":"2016","unstructured":"Ha KH, Kim DJ. Epidemiology of childhood obesity in Korea. Endocrinol Metab (Seoul). 2016;31:510\u20138.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"702_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","volume":"74","author":"G Diene","year":"2010","unstructured":"Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, et al. Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database. Horm Res Paediatr. 2010;74:121\u20138.","journal-title":"Horm Res Paediatr"},{"key":"702_CR20","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1210\/jc.2010-1733","volume":"96","author":"AM Haqq","year":"2011","unstructured":"Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab. 2011;96:E225\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR21","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","volume":"87","author":"C Hoybye","year":"2002","unstructured":"Hoybye C, Hilding A, Jacobsson H, Thoren M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab. 2002;87:3590\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/JPEM.2006.19.7.911","volume":"19","author":"AG Krochik","year":"2006","unstructured":"Krochik AG, Ozuna B, Torrado M, Chertkoff L, Mazza C. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2006;19:911\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"702_CR23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0026-0495(96)90181-X","volume":"45","author":"DP Schuster","year":"1996","unstructured":"Schuster DP, Osei K, Zipf WB. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism. 1996;45:1514\u201320.","journal-title":"Metabolism"},{"key":"702_CR24","volume-title":"Gerasimidis K","author":"MJ Khan","year":"2016","unstructured":"Khan MJ. Gerasimidis K. Shaikh MG. Mechanisms of obesity in Prader-Willi syndrome. Pediatr Obes: Edwards CA; 2016."},{"key":"702_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.ijo.0803115","volume":"30","author":"L Kennedy","year":"2006","unstructured":"Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond). 2006;30:382\u20137.","journal-title":"Int J Obes (Lond)"},{"key":"702_CR26","doi-asserted-by":"crossref","unstructured":"Cadoudal T, Buleon M, Sengenes C, Diene G, Desneulin F, Molinas C, et al. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond). 2014;38:1234\u201340.","DOI":"10.1038\/ijo.2014.3"},{"key":"702_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","volume":"50","author":"RJ Kuppens","year":"2015","unstructured":"Kuppens RJ, Di\u00e8ne G, Bakker NE, Molinas C, Faye S, Nicolino M, et al. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader\u2013Willi syndrome. Endocrine. 2015;50:633\u201342.","journal-title":"Endocrine"},{"key":"702_CR28","doi-asserted-by":"crossref","unstructured":"Betancourt-Albrecht M, Cunningham GR. Hypogonadism and diabetes. Int J Impot Res. 0000;15:S14-S20.","DOI":"10.1038\/sj.ijir.3901031"},{"key":"702_CR29","volume":"11","author":"KJ Yun","year":"2016","unstructured":"Yun KJ, Han K, Kim MK, Park YM, Baek KH, Song KH, et al. Insulin resistance distribution and cut-off value in Koreans from the 2008-2010 Korean National Health and nutrition examination survey. PLoS One. 2016;11:e0154593.","journal-title":"PLoS One"},{"key":"702_CR30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.2040-1124.2011.00113.x","volume":"2","author":"C Yamada","year":"2011","unstructured":"Yamada C, Mitsuhashi T, Hiratsuka N, Inabe F, Araida N, Takahashi E. Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig. 2011;2:373\u20136.","journal-title":"J Diabetes Investig"},{"key":"702_CR31","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500\u20133.","journal-title":"Pediatrics"},{"key":"702_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1743-7075-7-26","volume":"7","author":"A Esteghamati","year":"2010","unstructured":"Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010;7:26.","journal-title":"Nutr Metab (Lond)"},{"key":"702_CR33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-0004.2004.00392.x","volume":"67","author":"Z Talebizadeh","year":"2005","unstructured":"Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet. 2005;67:230\u20139.","journal-title":"Clin Genet"},{"key":"702_CR34","doi-asserted-by":"crossref","unstructured":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"702_CR35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2337\/dc10-2300","volume":"34","author":"M Chiu","year":"2011","unstructured":"Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741\u20138.","journal-title":"Diabetes Care"},{"key":"702_CR36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mpd.2000.105369","volume":"137","author":"SE Myers","year":"2000","unstructured":"Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr. 2000;137:42\u20139.","journal-title":"J Pediatr"},{"key":"702_CR37","first-page":"239","volume":"59","author":"D L'Allemand","year":"2003","unstructured":"L'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Horm Res. 2003;59:239\u201348.","journal-title":"Horm Res"},{"key":"702_CR38","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","volume":"98","author":"NE Bakker","year":"2013","unstructured":"Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, et al. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab. 2013;98:4013\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apa.12898","volume":"104","author":"C Hoybye","year":"2015","unstructured":"Hoybye C. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition. Acta Paediatr. 2015;104:422\u20137.","journal-title":"Acta Paediatr"},{"key":"702_CR40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.ijo.0801636","volume":"25","author":"SY Nam","year":"2001","unstructured":"Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2001;25:1101\u20137.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"702_CR41","first-page":"22","volume":"48","author":"R Holt","year":"2003","unstructured":"Holt R. Growth hormone: a potential treatment option in diabetes? Diabetes Voice. 2003;48:22\u20134.","journal-title":"Diabetes Voice"},{"key":"702_CR42","first-page":"727","volume":"82","author":"G Johannsson","year":"1997","unstructured":"Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 1997;82:727\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem-70-4-1114","volume":"70","author":"PJ Campbell","year":"1990","unstructured":"Campbell PJ, Gerich JE. Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab. 1990;70:1114\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"702_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/cs0870201","volume":"87","author":"F Salomon","year":"1994","unstructured":"Salomon F, Cuneo RC, Umpleby AM, Sonksen PH. Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin Sci (Lond). 1994;87:201\u20136.","journal-title":"Clin Sci (Lond)"},{"key":"702_CR45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/028134399750002755","volume":"17","author":"PE Wandell","year":"1999","unstructured":"Wandell PE. Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes. Scand J Prim Health Care. 1999;17:116\u201321.","journal-title":"Scand J Prim Health Care"},{"key":"702_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1056-8727(01)00184-2","volume":"16","author":"B Nazimek-Siewniak","year":"2002","unstructured":"Nazimek-Siewniak B, Moczulski D, Grzeszczak W. Risk of macrovascular and microvascular complications in type 2 diabetes: results of longitudinal study design. J Diabetes Complicat. 2002;16:271\u20136.","journal-title":"J Diabetes Complicat"},{"key":"702_CR47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.endonu.2011.01.006","volume":"58","author":"FJ Ca\u00f1izo G\u00f3mez del","year":"2011","unstructured":"del Ca\u00f1izo G\u00f3mez FJ, Fern\u00e1ndez P\u00e9rez C, Moreno Ruiz I, de Gorospe P-JC, Silveira Rodr\u00edguez B, Gonz\u00e1lez Losada T, et al. Microvascular complications and risk factors in patients with type 2 diabetes. Endocrinol Nutr. 2011;58:163\u20138.","journal-title":"Endocrinol Nutr"},{"key":"702_CR48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-8628(19970822)71:3<267::AID-AJMG3>3.0.CO;2-R","volume":"71","author":"R Bassali","year":"1997","unstructured":"Bassali R, Hoffman WH, Chen H, Tuck-Muller CM. Hyperlipidemia, insulin-dependent diabetes mellitus, and rapidly progressive diabetic retinopathy and nephropathy in Prader-Willi syndrome with del(15)(q11.2q13). Am J Med Genet. 1997;71:267\u201370.","journal-title":"Am J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T08:09:28Z","timestamp":1504080568000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0702-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0702-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"article-number":"146"}}